Mode
Text Size
Log in / Sign up

Left Ventricular Hypertrophy

6 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Left Ventricular Hypertrophy

4 trials tracked for Left Ventricular Hypertrophy: 4 in phase 3 or 4.

4Trials tracked
4Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 3 3
  1. Phase 4 Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP) Completed
  2. Phase 3 The CLEVER Study - Coreg And Left Ventricular Mass Regression Completed
  3. Phase 3 Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension Completed
  4. Phase 3 The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4 Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Left Ventricular Hypertrophy

Can echocardiographic strain imaging find cardiac amyloidosis in patients with left ventricular hypertrophy?

Yes, echocardiographic strain imaging, especially the apical sparing ratio, can help detect cardiac amyloidosis in patients with left ventricular hypertrophy, but its accuracy is moderate and varies by clinical context.

Full answer →
Why might my left ventricular mass be higher if my stress test results are abnormal?

Higher left ventricular mass can cause abnormal stress test results by increasing microvascular resistance, even without blocked arteries.

Full answer →